与 gabapentinoids 相关的精神疾病:基于FAERS数据库的分析,从2004年到2023年
Jingjing Li1, Zhicheng Dai2, Zhengwei Zhang3
1Department of Neonatal, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Expert opinion on drug safety
|January 3, 2025
概括
像 gabapentin 和 pregabalin 这样的 gabapentinoids 与增加的精神疾病有关,包括焦虑和自杀念头. 这项对FDA数据的分析突出了需要进一步调查的重大安全问题.
科学领域:
- 药物监督 药物监督 药物监督
- 神经科学是一个神经科学.
- 临床药理学 临床药理学
背景情况:
- gabapentinoids (gabapentin,pregabalin) 是广泛用于治疗神经病痛的药物.
- 越来越多地认识到与 gabapentinoid 使用相关的安全问题.
- 这项研究调查了与 gabapentinoids 相关的精神病不良事件.
研究的目的:
- 分析美国FDA不良事件报告系统 (FAERS) 数据库.
- 评估精神疾病的风险作为 gabapentinoids 的不良影响.
- 为了比较加巴丁和普雷加巴林的精神病学不良事件概况.
主要方法:
- 在FAERS数据 (2004-2023) 上使用ROR,PRR,BCPNN和MGPS进行不成比例分析.
- 卡普兰-梅尔和日志等级测试用于发病率和发病分析.
- 对死亡率和住院率进行奇平方测试.
主要成果:
- 在174,321份不良事件报告中,超过22%涉及精神疾病.
- gabapentinoids 与精神疾病的发病率增加有关,包括焦虑和自杀念头.
- 在 gabapentin 和 pregabalin 之间观察到发生率和健康结果的显著差异.
结论:
- gabapentinoid 使用与精神疾病之间存在明显的相关性.
- 进一步的研究是有必要的,以了解潜在的机制.
- 制定这些不良影响的预防策略至关重要.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
Sedatives and Hypnotics Drugs: Miscellaneous Agents
145
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
145
Antidepressant Drugs: MAOIs and Other Agents
192
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
192
Antiepileptic Drugs: GABAergic Pathway Potentiators
321
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
321
Antiepileptic Drugs: Glutamate Antagonists
279
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
279
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
240
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
240


